Pulse Biosciences Stock Forecast
NASDAQ: PLSEHealth CareMedical/Dental InstrumentsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
PLSE analyst consensus
Consensus (6 analysts)
strong_buy
Avg. price target
$56.50+13.05%
- Strong buy 1
- Buy 5
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 6 Wall Street analysts covering Pulse Biosciences (2026-10-07), 6 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $56.50, with a high estimate of $73.00 and a low estimate of $35.00. The average target implies upside of 13.0% from the current price of $49.98.
The spread between the highest and lowest targets is 108.6%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for PLSE.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 17% |
| Buy | 5 | 83% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $35.00 | -29.97% |
| Average target | $56.50 | +13.05% |
| High target | $73.00 | +46.06% |